Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.
Wada A, Kobayashi N, Asanuma S, Matsuoka S, Kosugi M, Fujii S, Noguchi S, Miyazono T, Nakata M, Ota S, Imai K, Hirano T, Ogasawara M, Kiyama Y, Kasai M. Wada A, et al. Among authors: miyazono t. Int J Hematol. 2011 Jan;93(1):118-22. doi: 10.1007/s12185-010-0737-z. Epub 2010 Dec 23. Int J Hematol. 2011. PMID: 21181316
Recurrence of IgG4-related disease following treatment with rituximab.
Murakami J, Matsui S, Ishizawa S, Arita K, Wada A, Miyazono T, Hounoki H, Shinoda K, Taki H, Sugiyama T. Murakami J, et al. Among authors: miyazono t. Mod Rheumatol. 2013 Nov;23(6):1226-30. doi: 10.1007/s10165-012-0738-2. Epub 2012 Sep 6. Mod Rheumatol. 2013. PMID: 22956241
Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma.
Nakano N, Takatsuka Y, Kubota A, Tokunaga M, Miyazono T, Tabuchi T, Odawara J, Tokunaga M, Makino T, Takeuchi S, Ito Y, Utsunomiya A. Nakano N, et al. Among authors: miyazono t. Int J Hematol. 2021 Jun;113(6):861-871. doi: 10.1007/s12185-021-03102-0. Epub 2021 Feb 16. Int J Hematol. 2021. PMID: 33594654 Clinical Trial.
Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma.
Nakano N, Takatsuka Y, Kubota A, Tokunaga M, Miyazono T, Tabuchi T, Odawara J, Tokunaga M, Makino T, Takeuchi S, Ito Y, Utsunomiya A. Nakano N, et al. Among authors: miyazono t. Int J Hematol. 2021 Jun;113(6):950. doi: 10.1007/s12185-021-03125-7. Int J Hematol. 2021. PMID: 33730358 No abstract available.
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Sakai T, Masaki Y, Otsuki N, Sakamaki I, Kishi S, Miyazono T, Urasaki Y, Murakami J, Satoh T, Nakamura T, Iwao H, Nakajima A, Kawanami T, Miki M, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Ueda T. Sakai T, et al. Among authors: miyazono t. Med Oncol. 2015 Sep;32(9):232. doi: 10.1007/s12032-015-0677-9. Epub 2015 Aug 15. Med Oncol. 2015. PMID: 26275804 Free PMC article. Clinical Trial.
31 results